ANIMATION

Gleevec (imatinib) MOA

Share this animation:

Kit is a receptor tyrosine kinase that activates of a number of pathways that direct cell proliferation, survival, and apoptosis. Mutations in Kit that result in constitutive oligomerization in the absence of ligand can drive continuous oncogenic signaling. The majority of gastrointestinal stromal tumor (GIST) cells have been found to present with overactive Kit signaling. Gleevec, or Glivec (imatinib mesylate) competitively binds to the ATP binding pocket of both active and inactive Kit, preventing downstream signaling. Kit inhibition by imatinib may induce both apoptosis and quiescence in KIT+ GIST cells.

Share It:
Contact XVIVO

Client


Novartis

My experience working with XVIVO can be summed up in one word: Confidence. Confidence in what the quality of the final animation would be, as well as confidence in their recommendations in regard to executing the animation from the initial pre-production meetings throughout the life of the project, until the final delivery. Confidence from the very first day that they would do what they said, when they said they would do it, and deliver high quality multimedia on time, and on budget.

VP, Director of Production, JUICE Pharma Advertising
Share this animation: